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W
orld Kidney Day, a joint initiative of 
the International Society of Neph-
rology (ISN) and the International 
Federation of Kidney Foundations 
(IFKF), aims to spread the crucial message that 
kidney disease is common, harmful, and treatable.
Common because chronic kidney disease 
(CKD), defi ned as a glomerular fi ltration rate of 
less than 60 ml per minute and/or the presence 
of microalbuminuria or proteinuria, has now 
been consistently shown to aff ect about 10% of 
the adult population in studies of diff erent races 
living on diff erent continents worldwide.1–5
Harmful not just because some of these patients 
progress to end-stage renal disease (ESRD), but 
more because these renal abnormalities are 
associated with a manyfold increase in risk of 
cardiovascular complications and premature car-
diovascular death.6,7 Indeed, the risk of prema-
ture death primarily from cardiovascular disease 
is, on average, 100-fold higher in patients with 
CKD than the risk of ESRD.8
Treatable because there is now strong scientifi c 
evidence that early detection, altering lifestyle 
factors, and aggressive control of blood pres-
sure, can not only slow or halt the progression of 
CKD to ESRD but can also signifi cantly reduce 
the incidence of cardiovascular disease that 
leads to premature death in the majority of these 
patients.9–13
Cardiovascular disease is today by far the most 
common cause of premature death worldwide.14 
We do not yet know exactly how many people 
dying of premature cardiovascular disease have 
CKD and might have benefi ted from early detec-
tion and treatment aimed at the kidney, but the 
number is certainly very large.
When we as a renal community become aware 
that early-detection programs focused on the kid-
ney can identify large numbers of patients who 
may be spared from other health complications 
or even premature death by simple interventions, 
we incur, in our view, a moral and ethical impera-
tive to advocate for the implementation of such 
programs. Th at such programs can be successful 
and cost eff ective has now been shown in several 
proof-of-concept prevention projects sponsored 
by the ISN and others.15–18
Th e four major United States renal societies, 
in celebration of World Kidney Day 2007, have 
jointly described and called for a comprehensive 
change in both funding and delivery of renal 
health care in the United States to emphasize early 
detection and prevention.19 We strongly endorse 
their conclusions and recommendations and feel 
these could be adapted to cultural and economic 
realities in other developed and developing coun-
tries where there is also an urgent need for this 
message to be heard.
How can we deliver our message of preven-
tion worldwide? One of the greatest challenges 
we face is ignorance about the kidneys. Surveys, 
even in better-educated and developed countries, 
have shown that less than 5% of the population 
can provide accurate answers to questions about 
where the kidneys are located and what they do. 
Th is is because kidney disease, when viewed solely 
in the context of ESRD, is essentially an orphan 
disease, aff ecting less than 0.2% of the population. 
And by that defi nition it does not even exist in 
many parts of the world where no renal replace-
ment therapy options are available and therefore 
no patients with ESRD survive.
To overcome this ignorance about an ‘invisible’ 
disease such as CKD, we will build on the remark-
able success of the fi rst World Kidney Day, held 
on 9 March 2006 and celebrated in 45 countries 
around the world. Th e creativity shown by groups 
in all of these countries was extraordinary. Local 
events included walkathons, marathons, auctions, 
sales of T shirts and other paraphernalia, screen-
ing programs, educational seminars, and media 
interviews. Meetings were arranged that led to 
proclamations and endorsement of World Kidney 
Day 2006 by a number of government offi  cials in 
many cities, states, and countries.
We want to capture and build on that remark-
able local energy in 2007. ‘Tool kits’ have been 
made available to all renal organizations and 
contain suggestions for events, posters, and a 
variety of media releases that can be used in any 
language. We are encouraging the use of a sim-
ple slogan — “Are your kidneys OK?” — to raise 
curiosity among the general public. Professional 
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Scientifi c Advisory Board to provide a coordinat-
ing center for all World Kidney Day activities and 
maintain a website (www.worldkidneyday.org) 
that makes all informational materials available 
to anyone, free of charge.
But World Kidney Day 2007 is not only our cause 
at ISN or IFKF. It is a cause that involves all of us 
in the renal community worldwide — physicians, 
scientists, nurses and other health-care providers, 
patients, administrators, health-policy experts, 
government offi  cials, nephrology organizations, 
and foundations. All need to be aware of the ways 
in which more attention to the kidney in the setting 
of government policies can lead to major benefi ts 
both to patients and to health-care budgets.
The readers of this Editorial, mostly neph-
rologists, need to continue to be the outspoken 
advocates for our patients that we have always 
been — especially now, when the discoveries we 
have made ourselves in the past decade put us 
in a much stronger position to demonstrate that 
increased awareness of the role of the kidney, 
particularly in the epidemic of diabetes and car-
diovascular disease worldwide, can truly have a 
major impact on global public health.
We urge you to become involved in World 
Kidney Day this year and thereaft er. Participate 
in events organized by your local societies and 
foundations, organize events if none is planned in 
your area, involve your hospitals and institutions, 
meet with local government offi  cials such as may-
ors and public-health offi  cers, contact your local 
media and make yourself available for interviews 
and comments. And, equally important — share 
with us and others what you are doing through 
the World Kidney Day website!
Th e message of World Kidney Day is that kid-
ney disease is common, harmful, and treatable. 
On 8 March 2007, let’s ensure that hundreds of 
thousands of people worldwide ask the question 
“Are your kidneys OK?” and try to fi nd out the 
answer.
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